Abstract
ObjectiveTo evaluate signal transducer and activator of transcription 3 (STAT3) inhibition we conducted a co-clinical trial testing danvatirsen, a STAT3 antisense oligonucleotide (ASO) and checkpoint inhibition in conjunction with preclinical...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have